Class IIOngoing

Lil Drug Store recall

FDA recall D-0632-2026 · initiated Jun 2, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 24, 2026How we research

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations; deficiencies observed during FDA inspection

Details

Product: Lil Drug Store, Triple Antibiotic Ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Polymyxin-B Sulfate (5000 units), net wt. 0.5 oz (14.2g), Product distributed by: Lil' Drug Store Products, Inc., 9300 Earhart Lane SW, Cedar Rapids, IA 52404, Made in India, UPC 3 66715 97310 8.
Recalling company: Dabur India Limited
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: US Nationwide.
Initiated: Jun 2, 2026
FDA report date: Jun 24, 2026

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0632-2026 ↗

← All drug recalls